Industry Research Reports

Home > Reports > Chemical & Material > Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 145 Pages

Report ld: 3565554

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Indapamide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Indapamide API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Indapamide API by region & country, by Type, and by Application.

The Indapamide API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Indapamide API.

MARKET SEGMENTATION

By Company

Otto Brandes
Biotechnica Pharma Global
CHEMO
Hepartex
Octavius Pharma Pvt. Ltd
Torrent Pharmaceuticals Limited
PharmaZell
Recipharm AB
Bioindustria L.I.M. Spa
Ipca Laboratories
Laboratori Alchemia Srl
Supra Chemicals
Suzhou Lixin Pharmaceutical
Refarmed Chemicals
Osmopharm
Tianjin Pacific Chemical & Pharma
Guangzhou Tosun Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Indapamide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Indapamide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Indapamide API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Indapamide API Product Introduction

1.2 Global Indapamide API Market Size Forecast

1.2.1 Global Indapamide API Sales Value (2020-2031)

1.2.2 Global Indapamide API Sales Volume (2020-2031)

1.2.3 Global Indapamide API Sales Price (2020-2031)

1.3 Indapamide API Market Trends & Drivers

1.3.1 Indapamide API Industry Trends

1.3.2 Indapamide API Market Drivers & Opportunity

1.3.3 Indapamide API Market Challenges

1.3.4 Indapamide API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Indapamide API Players Revenue Ranking (2024)

2.2 Global Indapamide API Revenue by Company (2020-2025)

2.3 Global Indapamide API Players Sales Volume Ranking (2024)

2.4 Global Indapamide API Sales Volume by Company Players (2020-2025)

2.5 Global Indapamide API Average Price by Company (2020-2025)

2.6 Key Manufacturers Indapamide API Manufacturing Base and Headquarters

2.7 Key Manufacturers Indapamide API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Indapamide API

2.9 Indapamide API Market Competitive Analysis

2.9.1 Indapamide API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Indapamide API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.2 Global Indapamide API Sales Value by Type

3.2.1 Global Indapamide API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Indapamide API Sales Value, by Type (2020-2031)

3.2.3 Global Indapamide API Sales Value, by Type (%) (2020-2031)

3.3 Global Indapamide API Sales Volume by Type

3.3.1 Global Indapamide API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Indapamide API Sales Volume, by Type (2020-2031)

3.3.3 Global Indapamide API Sales Volume, by Type (%) (2020-2031)

3.4 Global Indapamide API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Others

4.2 Global Indapamide API Sales Value by Application

4.2.1 Global Indapamide API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Indapamide API Sales Value, by Application (2020-2031)

4.2.3 Global Indapamide API Sales Value, by Application (%) (2020-2031)

4.3 Global Indapamide API Sales Volume by Application

4.3.1 Global Indapamide API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Indapamide API Sales Volume, by Application (2020-2031)

4.3.3 Global Indapamide API Sales Volume, by Application (%) (2020-2031)

4.4 Global Indapamide API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Indapamide API Sales Value by Region

5.1.1 Global Indapamide API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Indapamide API Sales Value by Region (2020-2025)

5.1.3 Global Indapamide API Sales Value by Region (2026-2031)

5.1.4 Global Indapamide API Sales Value by Region (%), (2020-2031)

5.2 Global Indapamide API Sales Volume by Region

5.2.1 Global Indapamide API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Indapamide API Sales Volume by Region (2020-2025)

5.2.3 Global Indapamide API Sales Volume by Region (2026-2031)

5.2.4 Global Indapamide API Sales Volume by Region (%), (2020-2031)

5.3 Global Indapamide API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Indapamide API Sales Value, 2020-2031

5.4.2 North America Indapamide API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Indapamide API Sales Value, 2020-2031

5.5.2 Europe Indapamide API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Indapamide API Sales Value, 2020-2031

5.6.2 Asia Pacific Indapamide API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Indapamide API Sales Value, 2020-2031

5.7.2 South America Indapamide API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Indapamide API Sales Value, 2020-2031

5.8.2 Middle East & Africa Indapamide API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Indapamide API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Indapamide API Sales Value

6.2.1 Key Countries/Regions Indapamide API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Indapamide API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Indapamide API Sales Value, 2020-2031

6.3.2 United States Indapamide API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Indapamide API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Indapamide API Sales Value, 2020-2031

6.4.2 Europe Indapamide API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Indapamide API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Indapamide API Sales Value, 2020-2031

6.5.2 China Indapamide API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Indapamide API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Indapamide API Sales Value, 2020-2031

6.6.2 Japan Indapamide API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Indapamide API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Indapamide API Sales Value, 2020-2031

6.7.2 South Korea Indapamide API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Indapamide API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Indapamide API Sales Value, 2020-2031

6.8.2 Southeast Asia Indapamide API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Indapamide API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Indapamide API Sales Value, 2020-2031

6.9.2 India Indapamide API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Indapamide API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Otto Brandes

7.1.1 Otto Brandes Company Information

7.1.2 Otto Brandes Introduction and Business Overview

7.1.3 Otto Brandes Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Otto Brandes Indapamide API Product Offerings

7.1.5 Otto Brandes Recent Development

7.2 Biotechnica Pharma Global

7.2.1 Biotechnica Pharma Global Company Information

7.2.2 Biotechnica Pharma Global Introduction and Business Overview

7.2.3 Biotechnica Pharma Global Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Biotechnica Pharma Global Indapamide API Product Offerings

7.2.5 Biotechnica Pharma Global Recent Development

7.3 CHEMO

7.3.1 CHEMO Company Information

7.3.2 CHEMO Introduction and Business Overview

7.3.3 CHEMO Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 CHEMO Indapamide API Product Offerings

7.3.5 CHEMO Recent Development

7.4 Hepartex

7.4.1 Hepartex Company Information

7.4.2 Hepartex Introduction and Business Overview

7.4.3 Hepartex Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Hepartex Indapamide API Product Offerings

7.4.5 Hepartex Recent Development

7.5 Octavius Pharma Pvt. Ltd

7.5.1 Octavius Pharma Pvt. Ltd Company Information

7.5.2 Octavius Pharma Pvt. Ltd Introduction and Business Overview

7.5.3 Octavius Pharma Pvt. Ltd Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Octavius Pharma Pvt. Ltd Indapamide API Product Offerings

7.5.5 Octavius Pharma Pvt. Ltd Recent Development

7.6 Torrent Pharmaceuticals Limited

7.6.1 Torrent Pharmaceuticals Limited Company Information

7.6.2 Torrent Pharmaceuticals Limited Introduction and Business Overview

7.6.3 Torrent Pharmaceuticals Limited Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Torrent Pharmaceuticals Limited Indapamide API Product Offerings

7.6.5 Torrent Pharmaceuticals Limited Recent Development

7.7 PharmaZell

7.7.1 PharmaZell Company Information

7.7.2 PharmaZell Introduction and Business Overview

7.7.3 PharmaZell Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 PharmaZell Indapamide API Product Offerings

7.7.5 PharmaZell Recent Development

7.8 Recipharm AB

7.8.1 Recipharm AB Company Information

7.8.2 Recipharm AB Introduction and Business Overview

7.8.3 Recipharm AB Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Recipharm AB Indapamide API Product Offerings

7.8.5 Recipharm AB Recent Development

7.9 Bioindustria L.I.M. Spa

7.9.1 Bioindustria L.I.M. Spa Company Information

7.9.2 Bioindustria L.I.M. Spa Introduction and Business Overview

7.9.3 Bioindustria L.I.M. Spa Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Bioindustria L.I.M. Spa Indapamide API Product Offerings

7.9.5 Bioindustria L.I.M. Spa Recent Development

7.10 Ipca Laboratories

7.10.1 Ipca Laboratories Company Information

7.10.2 Ipca Laboratories Introduction and Business Overview

7.10.3 Ipca Laboratories Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Ipca Laboratories Indapamide API Product Offerings

7.10.5 Ipca Laboratories Recent Development

7.11 Laboratori Alchemia Srl

7.11.1 Laboratori Alchemia Srl Company Information

7.11.2 Laboratori Alchemia Srl Introduction and Business Overview

7.11.3 Laboratori Alchemia Srl Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Laboratori Alchemia Srl Indapamide API Product Offerings

7.11.5 Laboratori Alchemia Srl Recent Development

7.12 Supra Chemicals

7.12.1 Supra Chemicals Company Information

7.12.2 Supra Chemicals Introduction and Business Overview

7.12.3 Supra Chemicals Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Supra Chemicals Indapamide API Product Offerings

7.12.5 Supra Chemicals Recent Development

7.13 Suzhou Lixin Pharmaceutical

7.13.1 Suzhou Lixin Pharmaceutical Company Information

7.13.2 Suzhou Lixin Pharmaceutical Introduction and Business Overview

7.13.3 Suzhou Lixin Pharmaceutical Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Suzhou Lixin Pharmaceutical Indapamide API Product Offerings

7.13.5 Suzhou Lixin Pharmaceutical Recent Development

7.14 Refarmed Chemicals

7.14.1 Refarmed Chemicals Company Information

7.14.2 Refarmed Chemicals Introduction and Business Overview

7.14.3 Refarmed Chemicals Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Refarmed Chemicals Indapamide API Product Offerings

7.14.5 Refarmed Chemicals Recent Development

7.15 Osmopharm

7.15.1 Osmopharm Company Information

7.15.2 Osmopharm Introduction and Business Overview

7.15.3 Osmopharm Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Osmopharm Indapamide API Product Offerings

7.15.5 Osmopharm Recent Development

7.16 Tianjin Pacific Chemical & Pharma

7.16.1 Tianjin Pacific Chemical & Pharma Company Information

7.16.2 Tianjin Pacific Chemical & Pharma Introduction and Business Overview

7.16.3 Tianjin Pacific Chemical & Pharma Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Tianjin Pacific Chemical & Pharma Indapamide API Product Offerings

7.16.5 Tianjin Pacific Chemical & Pharma Recent Development

7.17 Guangzhou Tosun Pharmaceutical

7.17.1 Guangzhou Tosun Pharmaceutical Company Information

7.17.2 Guangzhou Tosun Pharmaceutical Introduction and Business Overview

7.17.3 Guangzhou Tosun Pharmaceutical Indapamide API Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Guangzhou Tosun Pharmaceutical Indapamide API Product Offerings

7.17.5 Guangzhou Tosun Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Indapamide API Industrial Chain

8.2 Indapamide API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Indapamide API Sales Model

8.5.2 Sales Channel

8.5.3 Indapamide API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Indapamide API Market Trends

Table 2. Indapamide API Market Drivers & Opportunity

Table 3. Indapamide API Market Challenges

Table 4. Indapamide API Market Restraints

Table 5. Global Indapamide API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Indapamide API Revenue Market Share by Company (2020-2025)

Table 7. Global Indapamide API Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Indapamide API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Indapamide API Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Indapamide API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Indapamide API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Indapamide API

Table 13. Global Indapamide API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Indapamide API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Indapamide API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Indapamide API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Indapamide API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Indapamide API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Indapamide API Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Indapamide API Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Indapamide API Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Indapamide API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Indapamide API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Indapamide API Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Indapamide API Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Indapamide API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Indapamide API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Indapamide API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Indapamide API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Indapamide API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Indapamide API Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Indapamide API Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Indapamide API Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Indapamide API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Indapamide API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Indapamide API Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Indapamide API Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Indapamide API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Indapamide API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Indapamide API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Indapamide API Sales Value by Region (2020-2025) & (%)

Table 44. Global Indapamide API Sales Value by Region (2026-2031) & (%)

Table 45. Global Indapamide API Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Indapamide API Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Indapamide API Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Indapamide API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Indapamide API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Indapamide API Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Indapamide API Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Indapamide API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Indapamide API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Indapamide API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Indapamide API Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Indapamide API Sales Volume, (2026-2031) & (Kg)

Table 57. Otto Brandes Company Information

Table 58. Otto Brandes Introduction and Business Overview

Table 59. Otto Brandes Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. Otto Brandes Indapamide API Product Offerings

Table 61. Otto Brandes Recent Development

Table 62. Biotechnica Pharma Global Company Information

Table 63. Biotechnica Pharma Global Introduction and Business Overview

Table 64. Biotechnica Pharma Global Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. Biotechnica Pharma Global Indapamide API Product Offerings

Table 66. Biotechnica Pharma Global Recent Development

Table 67. CHEMO Company Information

Table 68. CHEMO Introduction and Business Overview

Table 69. CHEMO Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. CHEMO Indapamide API Product Offerings

Table 71. CHEMO Recent Development

Table 72. Hepartex Company Information

Table 73. Hepartex Introduction and Business Overview

Table 74. Hepartex Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Hepartex Indapamide API Product Offerings

Table 76. Hepartex Recent Development

Table 77. Octavius Pharma Pvt. Ltd Company Information

Table 78. Octavius Pharma Pvt. Ltd Introduction and Business Overview

Table 79. Octavius Pharma Pvt. Ltd Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. Octavius Pharma Pvt. Ltd Indapamide API Product Offerings

Table 81. Octavius Pharma Pvt. Ltd Recent Development

Table 82. Torrent Pharmaceuticals Limited Company Information

Table 83. Torrent Pharmaceuticals Limited Introduction and Business Overview

Table 84. Torrent Pharmaceuticals Limited Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. Torrent Pharmaceuticals Limited Indapamide API Product Offerings

Table 86. Torrent Pharmaceuticals Limited Recent Development

Table 87. PharmaZell Company Information

Table 88. PharmaZell Introduction and Business Overview

Table 89. PharmaZell Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. PharmaZell Indapamide API Product Offerings

Table 91. PharmaZell Recent Development

Table 92. Recipharm AB Company Information

Table 93. Recipharm AB Introduction and Business Overview

Table 94. Recipharm AB Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. Recipharm AB Indapamide API Product Offerings

Table 96. Recipharm AB Recent Development

Table 97. Bioindustria L.I.M. Spa Company Information

Table 98. Bioindustria L.I.M. Spa Introduction and Business Overview

Table 99. Bioindustria L.I.M. Spa Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. Bioindustria L.I.M. Spa Indapamide API Product Offerings

Table 101. Bioindustria L.I.M. Spa Recent Development

Table 102. Ipca Laboratories Company Information

Table 103. Ipca Laboratories Introduction and Business Overview

Table 104. Ipca Laboratories Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Ipca Laboratories Indapamide API Product Offerings

Table 106. Ipca Laboratories Recent Development

Table 107. Laboratori Alchemia Srl Company Information

Table 108. Laboratori Alchemia Srl Introduction and Business Overview

Table 109. Laboratori Alchemia Srl Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 110. Laboratori Alchemia Srl Indapamide API Product Offerings

Table 111. Laboratori Alchemia Srl Recent Development

Table 112. Supra Chemicals Company Information

Table 113. Supra Chemicals Introduction and Business Overview

Table 114. Supra Chemicals Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 115. Supra Chemicals Indapamide API Product Offerings

Table 116. Supra Chemicals Recent Development

Table 117. Suzhou Lixin Pharmaceutical Company Information

Table 118. Suzhou Lixin Pharmaceutical Introduction and Business Overview

Table 119. Suzhou Lixin Pharmaceutical Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 120. Suzhou Lixin Pharmaceutical Indapamide API Product Offerings

Table 121. Suzhou Lixin Pharmaceutical Recent Development

Table 122. Refarmed Chemicals Company Information

Table 123. Refarmed Chemicals Introduction and Business Overview

Table 124. Refarmed Chemicals Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 125. Refarmed Chemicals Indapamide API Product Offerings

Table 126. Refarmed Chemicals Recent Development

Table 127. Osmopharm Company Information

Table 128. Osmopharm Introduction and Business Overview

Table 129. Osmopharm Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 130. Osmopharm Indapamide API Product Offerings

Table 131. Osmopharm Recent Development

Table 132. Tianjin Pacific Chemical & Pharma Company Information

Table 133. Tianjin Pacific Chemical & Pharma Introduction and Business Overview

Table 134. Tianjin Pacific Chemical & Pharma Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 135. Tianjin Pacific Chemical & Pharma Indapamide API Product Offerings

Table 136. Tianjin Pacific Chemical & Pharma Recent Development

Table 137. Guangzhou Tosun Pharmaceutical Company Information

Table 138. Guangzhou Tosun Pharmaceutical Introduction and Business Overview

Table 139. Guangzhou Tosun Pharmaceutical Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 140. Guangzhou Tosun Pharmaceutical Indapamide API Product Offerings

Table 141. Guangzhou Tosun Pharmaceutical Recent Development

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Indapamide API Downstream Customers

Table 145. Indapamide API Distributors List

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Indapamide API Product Picture

Figure 2. Global Indapamide API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Indapamide API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Indapamide API Sales Volume (2020-2031) & (Kg)

Figure 5. Global Indapamide API Sales Price (2020-2031) & (US$/Kg)

Figure 6. Indapamide API Report Years Considered

Figure 7. Global Indapamide API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Indapamide API Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Indapamide API Revenue in 2024

Figure 10. Indapamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Indapamide API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Indapamide API Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Indapamide API Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Indapamide API Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Indapamide API Price by Type (2020-2031) & (US$/Kg)

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Others

Figure 20. Global Indapamide API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Indapamide API Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Indapamide API Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 23. Global Indapamide API Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Indapamide API Price by Application (2020-2031) & (US$/Kg)

Figure 25. North America Indapamide API Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Indapamide API Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Indapamide API Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Indapamide API Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Indapamide API Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Indapamide API Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Indapamide API Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Indapamide API Sales Volume (%), (2020-2031)

Figure 37. United States Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 43. China Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 45. China Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 55. India Indapamide API Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Indapamide API Sales Value by Type (%), 2024 VS 2031

Figure 57. India Indapamide API Sales Value by Application (%), 2024 VS 2031

Figure 58. Indapamide API Industrial Chain

Figure 59. Indapamide API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Indapamide API market? zhanKai

The top companies in the global Indapamide API market are Otto Brandes、Biotechnica Pharma Global、CHEMO.

Related Reports

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
Global Indapamide API Market Research Report 2026
The global Indapamide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 150
USD 2900.00
(Single User License)
Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Indapamide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 104
USD 4250.00
(Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 174
USD 4900.00
(Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published Date: 2024-02-07
Pages: 113
USD 2900.00
(Single User License)

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 153
USD 3950.00 (Single User License)
Global Indapamide API Market Research Report 2026
The global Indapamide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 150
USD 2900.00 (Single User License)
Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Indapamide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 104
USD 4250.00 (Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 174
USD 4900.00 (Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published: 2024-02-07
Pages: 113
USD 2900.00 (Single User License)